Why Vertex Is Striking Another Gene-Editing Deal With a Company Not Named CRISPR Therapeutics - NewsBreak
#vertex
#namedcrisprtherapeutics
2 years ago By Hardik — Vertex is spending $41 million upfront in a collaboration with Mammoth Biosciences. The two companies will develop gene-editing therapies targeting two gen